Reply to H.W. Daniell and to L. Azoulay and S. Suissa

[1]  Y. Yamada,et al.  Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy. , 2011, International journal of radiation oncology, biology, physics.

[2]  H. Daniell.  Smoking, obesity, and statin therapy in the prognosis of prostate cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Suissa,et al.  Statins in the prevention of prostate cancer recurrence: are certain biases exaggerating the results? , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Weichselbaum,et al.  Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  K. Choe,et al.  The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy , 2009, Cancer.

[6]  M. Parmar,et al.  Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials , 2009, The Lancet. Oncology.

[7]  L. Kestin,et al.  The Optimum Duration of Combination Androgen Deprivation Therapy (ADT) with Prostate Cancer Radiotherapy: Determining the Duration-benefit Relationship from Multi-institutional Analysis , 2008 .

[8]  I. Ben-Sahra,et al.  The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level , 2008, Oncogene.

[9]  T. Fahey,et al.  How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials. , 2007, Family practice.

[10]  N J Wald,et al.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[11]  Henrik Grönberg,et al.  Prostate cancer epidemiology , 2003, The Lancet.

[12]  J. Egido,et al.  Anti-inflammatory and immunomodulatory effects of statins. , 2003, Kidney international.

[13]  G. Weitz-Schmidt,et al.  Statins as anti-inflammatory agents. , 2002, Trends in pharmacological sciences.

[14]  N Rifai,et al.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. , 2001, JAMA.

[15]  F. Mach,et al.  Statins as a newly recognized type of immunomodulator , 2000, Nature Medicine.